-
Opicapone, sold
under the
brand name Ongentys, is a
medication which is
administered together with
levodopa in
people with Parkinson's disease. Opicapone...
- Stalevo)
Opicapone (Ongentys)
Tolcapone (Tasmar) Not
marketed Nebicapone (BIA 3-202)
Neluxicapone Nitecapone (OR-462)
Entacapone and
opicapone are peripherally...
- the
development and
commercialization of the Parkinson's
disease drug,
opicapone, in
North America with the Portugal-based
pharmaceutical company Bial...
-
inhibitors such as entacapone,
opicapone, and tolcapone,
which are used in the
treatment of Parkinson's disease.
Entacapone and
opicapone are
peripherally selective...
-
entacapone (65),
nebicapone (96),
neluxicapone (119),
nitecapone (62),
opicapone (103),
tolcapone (66)
World Health Organization (2019). "International...
- in
peripheral sympathetically innervated tissues,
without CNS effects.
Opicapone (BIA 9-1067), Bial's
second pharmaceutical, is a COMT
inhibitor for the...
-
Safinamide N04BX01
Tolcapone N04BX02
Entacapone N04BX03
Budipine N04BX04
Opicapone N04CX01
Istradefylline "ATC (Anatomical
Therapeutic Chemical classification...
- 4-Hydroxyestrone→4-Methoxyestrone Inhibitors: 2-Hydroxyestradiol 2-Hydroxyestrone
Entacapone Nebicapone Neluxicapone Nitecapone Opicapone Quinalizarin Tolcapone...
- 4-Hydroxyestrone→4-Methoxyestrone Inhibitors: 2-Hydroxyestradiol 2-Hydroxyestrone
Entacapone Nebicapone Neluxicapone Nitecapone Opicapone Quinalizarin Tolcapone...
- 4-Hydroxyestrone→4-Methoxyestrone Inhibitors: 2-Hydroxyestradiol 2-Hydroxyestrone
Entacapone Nebicapone Neluxicapone Nitecapone Opicapone Quinalizarin Tolcapone...
